This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Quality of Care  • Quality of Care, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Moving From Illusion to Reality

David Classen, MD, MS

JAMA. 2003;289:1154-1156.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The importance of medication safety has been recognized for many years, but only recently has it reemerged as a major public health issue based on numerous recent studies and high-profile safety events.¹ Drug safety dates back to the 1950s, when in response to reports of chloramphenicol-associated aplastic anemia, the American Medical Association established an adverse drug reaction (ADR) reporting system and the Food and Drug Administration began requiring pharmaceutical manufacturers to report ADRs.¹ This effort to detect heretofore unknown, serious adverse effects of medications in postmarket use relied on voluntary reporting, which also became common practice in most health care organizations.

In the 1960s, Jick and colleagues² began to focus on the safety of drugs in everyday practice, using a concurrent study approach instead of voluntary reporting. The authors found that 30% of the medical inpatients in their study experienced at least 1 ADR during their . . . [Full Text of this Article]

Author Affiliation: University of Utah, Salt Lake City.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Jerry H. Gurwitz, Terry S. Field, Leslie R. Harrold, Jeffrey Rothschild, Kristin Debellis, Andrew C. Seger, Cynthia Cadoret, Leslie S. Fish, Lawrence Garber, Michael Kelleher, and David W. Bates
JAMA. 2003;289(9):1107-1116.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

National surveillance of emergency department visits for outpatient adverse drug events.
Budnitz et al.
JAMA 2006;296:1858-1866.
ABSTRACT | FULL TEXT  

Using Computer Technology to Detect, Measure, and Prevent Adverse Drug Events
Gardner and Evans
J. Am. Med. Inform. Assoc. 2004;11:535-536.
FULL TEXT  

Improving medication safety: the measurement conundrum and where to start
Classen and Metzger
Int J Qual Health Care 2003;15:i41-47.
ABSTRACT | FULL TEXT